Krystal Biotech News

Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow JonesMay 8 11:57 ET

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the

GlobeNewswireMay 8 07:00 ET

Krystal Biotech Reveals Eye Treatment Vector at ARVO 2024

TipRanksMay 8 06:14 ET

Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...

Yahoo FinanceMay 7 03:03 ET

Krystal Biotech's Battle to Scale VYJUVEK Production Amid Regulatory Hurdles and Soaring Demand

TipRanksMay 7 02:00 ET

Earnings Call Summary | Krystal Biotech(KRYS.US) Q1 2024 Earnings Conference

The following is a summary of the Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript:Financial Performance:Krystal Biotech reported a strong Q1 2024 with net revenues of $45.3 million and g

moomoo AIMay 6 16:12 ET · Conference Call

Express News | HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target

BenzingaMay 6 13:48 ET

Krystal Biotech Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 31.07% HC Wainwright & Co. → $200 Reiterates Buy → Buy 04/22/2024 31.07% HC Wainwright & Co. →

BenzingaMay 6 13:47 ET

Maintaining Buy Rating on Krystal Biotech: Strong VYJUVEK Sales and Promising Pipeline Despite EPS Miss

TipRanksMay 6 11:15 ET

Express News | Krystal Biotech Shares Edges Down 8.8% After Q1 Revenue Miss Expectations

ReutersMay 6 09:33 ET

Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024

Yahoo FinanceMay 6 09:31 ET

Sector Update: Health Care Stocks Gain Pre-Bell Monday

Health care stocks were gaining pre-bell Monday, with the Health Care Select Sector SPDR Fund (XLV) unchanged and the iShares Biotechnology ETF (IBB) adding 0.3%. BioNTech (BNTX) shares were down 2.6%

MT NewswiresMay 6 08:54 ET

Express News | Krystal Biotech Shares Are Trading Lower After the Company Reported Q1 Financial Results

BenzingaMay 6 08:32 ET

Express News | Krystal Biotech Shares Down 17% Premarket After Q1 Results

ReutersMay 6 08:26 ET

Krystal Biotech | 10-Q: Quarterly report

Futu NewsMay 6 08:19 ET · Announcements

Express News | Krystal Biotech Inc - Qtrly Shr $0.03

ReutersMay 6 08:06 ET

Express News | Krystal Biotech Expects Approximately $150M-$175M Of Adjusted R&D And SG&A Expense In 2024

BenzingaMay 6 08:05 ET

Express News | Krystal Biotech's Cash, Cash Equivalents, And Investments Totaled $622.3M On March 31, 2024

BenzingaMay 6 08:04 ET

Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q1 Revenue $45.3M, Vs. Street Est of $47.4M

08:04 AM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q1 Revenue $45.3M, vs. Street Est of $47.4M

MT NewswiresMay 6 08:04 ET

Krystal Biotech Misses Top-line and Bottom-line Estimates; Reaffirms FY24 Outlook

Seeking AlphaMay 6 08:03 ET